Saturday 31 October 2026
Export CTRE’s income statement to Excel — free account
CareTrust REIT, Inc.
CTRE Real Estate Reit Healthcare Facilities
CareTrust REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $476.4 million, up 60.8% from fiscal 2024. In the quarter to June 2026, revenue grew 43.5%, EPS grew 5.56%, free cash flow grew 89.0% and total debt rose 4.30%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
36.39
0.13
+0.36%
Follow CTRE
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
25.69 | 23.18 | 23.34 | 25.38 |
P/S ratio |
17.14 | 15.46 | 15.64 | 16.51 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
72.77 | 60.88 | 90.45 | 70.00 | |
P/B ratio |
1.84 | 1.82 | 1.98 | 2.10 | |
Price to Tangible BV |
1.84 | 1.82 | 1.98 | 2.10 | |
EV/Sales |
17.56 | 16.92 | 16.93 | 18.53 | |
EV/EBITDA |
20.01 | 19.25 | 19.35 | 21.14 | |
EV/Operating CF |
21.61 | 20.46 | 21.42 | 23.69 | |
EV/FCF |
(7.25) | (7.33) | (7.95) | (19.50) | |
Quick Ratio |
6.98 | 1.73 | 2.38 | 0.57 | |
Current Ratio |
6.98 | 1.73 | 2.38 | 0.57 | |
Net Debt/EBITDA |
1.61 | 5.91 | 5.29 | 8.05 | |
Debt/Assets |
17.56% | 17.37% | 17.08% | 20.32% | |
Debt/Equity |
0.22 | 0.22 | 0.22 | 0.27 | |
Asset Turnover |
0.11 | 0.11 | 0.11 | 0.11 | |
Operating CF/Net income |
1.35 | 1.09 | 1.13 | 1.51 | |
Capex/Depreciation |
(1.93) | (21.48) | (2.20) | (5.94) | |
Interest Coverage |
6.88 | 7.65 | 8.27 | 7.11 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
11.64% | 11.47% | 10.04% | 9.78% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
(0.05) | (0.12) | (0.11) | (0.14) | |
Graham Number |
23.95 | 26.39 | 25.60 | 26.24 | |
Earnings Yield |
3.89% | 4.31% | 4.28% | 3.94% | |
Free Cash Flow Yield |
(14.14%) | (14.93%) | (13.61%) | (5.76%) | |
Revenue per Share |
0.63 | 0.66 | 0.64 | 0.69 | |
Operating CF per Share |
0.48 | 0.59 | 0.41 | 0.58 | |
Capex per Share |
(0.23) | (3.24) | (0.34) | (0.88) | |
Free Cash Flow per Share |
0.24 | (2.65) | 0.07 | (0.30) | |
Cash per Share |
3.36 | 0.97 | 1.00 | 0.21 | |
Shareholders Equity per Share |
18.88 | 19.84 | 18.56 | 19.25 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
18.88 | 19.84 | 18.56 | 19.25 | |
Free Cash Flow |
51.51 | (539.43) | 15.48 | (70.47) | |
Working Capital |
616.76 | 87.97 | 137.60 | (51.44) | |
Capital Expenditures |
(49.40) | (660.39) | (74.89) | (205.21) | |
Net Current Asset Value |
(370.31) | (899.21) | (861.30) | (1,362.09) | |
EV/EBIT |
26.19 | 25.50 | 25.83 | 28.18 | |
Capex to Sales |
0.37 | 4.90 | 0.52 | 1.27 | |
Price to Operating Income |
25.56 | 23.29 | 23.87 | 25.10 | |
| Other line items | |||||
Average Receivables |
4.14 | 5.77 | 8.21 | 10.33 | |
Average Payables |
76.41 | 88.38 | 75.57 | 113.87 | |
Average Assets |
4,004.90 | 4,292.73 | 4,560.79 | 5,292.89 | |
Average Common Equity |
3,211.74 | 3,475.98 | 3,534.47 | 3,901.99 |
Columns are period end dates